b.demir

TL2 Moderator · Łódź

Contributes reviews on supplier material. Based in Łódź.

Joined 7 June 2025 · last posted 4d

80 posts, newest first. Showing up to 150.

Distinguishing a red flag from an inconvenience — a second dataset Replied, post #10 · Sourcing › Red flags · 24 Jul 2026 · 13 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
Seven-day rolling means and why weekly readings mislead Replied, post #91 · Outcomes › Progress reports · 23 Jul 2026 · 13 likes post #90 answers the question as asked. The question underneath it is different. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than…
Search filters: what is missing Replied, post #83 · Meta › Site feedback · 20 Jul 2026 · 20 likes Coming back to post #81, because the follow-up matters more than the original answer. Bugs and friction: the parts of the site that do not work the way you expected.…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #88 · Analytics › Home & field testing · 15 Jul 2026 · 14 likes post #87 answers the question as asked. The question underneath it is different. Sample handling matters: if a sample is contaminated or degraded before testing, the…
GLP-1 receptor distribution: central and peripheral Replied, post #89 · Pharmacology › Receptor biology · 13 Jul 2026 · 3 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #17 · Practice › Interactions · 12 Jul 2026 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #63 · Analytics › Home & field testing · 7 Jul 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #13 · Analytics › Mass spectrometry · 26 Jun 2026 · 5 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
How to ask a question when you cannot say why you are asking it Replied, post #21 · Start Here › How to Ask · 24 Jun 2026 · 11 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
About the Mass spectrometry category Replied, post #4 · Analytics › Mass spectrometry · 20 Jun 2026 · 10 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #79 · Devices › Syringes & needles · 20 Jun 2026 · 9 likes post #78 answers the question as asked. The question underneath it is different. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #9 · Compounds › Retatrutide · 19 Jun 2026 · 28 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #93 · Sourcing › Logistics · 6 Jun 2026 · 30 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #70 · Sourcing › Red flags · 5 Jun 2026 · 0 likes post #69 is right about the mechanism and I think understates the practical bit. Pricing patterns: unusually low prices for what are otherwise consistent with market…
Reading a trial's population section before its results Replied, post #59 · Evidence › Trials · 27 May 2026 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #28 · Practice › Storage & stability · 15 May 2026 · 20 likes Worth separating two things that post #24 runs together. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #119 · Compounds › Tirzepatide · 11 May 2026 · 0 likes Coming back to post #117, because the follow-up matters more than the original answer. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #75 · Start Here › Welcome · 6 May 2026 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Why the timeline is on the right and not the left — what changed since Replied, post #27 · Meta › Site feedback · 28 Apr 2026 · 20 likes I read post #25 twice before replying, because I had assumed the opposite. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post…
List price versus negotiated price versus what you pay Replied, post #89 · Access › Pricing · 15 Apr 2026 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #60 · Analytics › Method validation · 30 Mar 2026 · 0 likes post #59 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #24 · Lounge › Introductions · 9 Mar 2026 · 5 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #56 · Outcomes › Progress reports · 14 Feb 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #83 · Wellbeing › Mental health · 28 Jan 2026 · 5 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
Waist circumference technique and its repeatability Replied, post #41 · Outcomes › Progress reports · 21 Jan 2026 · 0 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
The most common factual error about semaglutide on the internet — what changed since Replied, post #4 · Compounds › Semaglutide · 8 Jan 2026 · 24 likes post #3 is right about the mechanism and I think understates the practical bit. The SELECT trial changed the positioning because it was the first cardiovascular outcome…
Tracking that stops updating and then resumes Replied, post #60 · Sourcing › Logistics · 25 Dec 2025 · 27 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Started this topic · Data & Tools › Datasets · 11 Dec 2025 · 2 likes Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? I have a specific reason for asking rather than idle curiosity, and the…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #17 · Compounds › Retatrutide · 4 Dec 2025 · 4 likes post #16 is right about the mechanism and I think understates the practical bit. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #27 · Data & Tools › Calculators · 4 Dec 2025 · 19 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #47 · Sourcing › Regulatory · 24 Nov 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #5 · Practice › Side effects · 21 Nov 2025 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
Request: export my own posts — one year on Replied, post #13 · Meta › Feature requests · 17 Nov 2025 · 9 likes post #12 is right about the mechanism and I think understates the practical bit. Tracking: staff will update the status of feature requests (under consideration,…
The anatomy of a question that gets answered within an hour — the long version Replied, post #4 · Start Here › How to Ask · 17 Oct 2025 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
When to stop reading forums, including this one Replied, post #37 · Wellbeing › Mental health · 16 Oct 2025 · 6 likes post #36 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 8 Oct 2025 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
A parcel that arrived warm: a decision process, not a verdict Replied, post #51 · Practice › Storage & stability · 23 Sep 2025 · 0 likes post #50 answers the question as asked. The question underneath it is different. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
Can a home kit substitute for a laboratory report? A careful no Replied, post #15 · Analytics › Home & field testing · 20 Sep 2025 · 0 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #39 · Compounds › Other compounds · 8 Sep 2025 · 5 likes Coming back to post #37, because the follow-up matters more than the original answer. This subcategory exists because some people will research compounds outside the…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #51 · Data & Tools › Datasets · 8 Sep 2025 · 1 like Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than retrospective recall. Prospective measurement (done while…
Confounding by indication, explained with a concrete example Replied, post #3 · Evidence › Study critique · 30 Aug 2025 · 6 likes post #2 answers the question as asked. The question underneath it is different. Publication bias: a single published positive trial is weaker evidence than multiple…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #13 · Sourcing › Regulatory · 29 Aug 2025 · 30 likes Picking up post #10: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
Comparing my trajectory with the trial curves, carefully Replied, post #40 · Outcomes › Progress reports · 25 Aug 2025 · 0 likes post #39 answers the question as asked. The question underneath it is different. Menstrual cycle: for people who menstruate, weight can shift by several pounds across…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #39 · Evidence › Journal club · 22 Aug 2025 · 8 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
How to research a compound with no human data without deceiving yourself Replied, post #59 · Compounds › Other compounds · 2 Aug 2025 · 16 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
Asking about a compound your prescriber has not heard of Replied, post #112 · Clinical › Prescriber conversations · 1 Aug 2025 · 22 likes Picking up post #109: that is the part I would want checked first. Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #75 · Compounds › Cagrilintide & amylin analogues · 28 Jul 2025 · 0 likes Worth separating two things that post #71 runs together. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether…
Coming back to: What published stability data actually covers, and what it does not Replied, post #84 · Practice › Storage & stability · 11 Jul 2025 · 28 likes This follows post #81 rather than contradicting it. Published stability data applies specifically to the formulation studied, under the specific conditions stated. It…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #61 · Evidence › Journal club · 30 Jun 2025 · 0 likes This follows post #58 rather than contradicting it. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 8 Jun 2025 · 21 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
A well-designed study with a badly written abstract Replied, post #129 · Evidence › Study critique · 4 Jun 2025 · 20 likes I read post #127 twice before replying, because I had assumed the opposite. Bias towards the null and bias away from the null: different criticisms have different…
Half-life, steady state, and accumulation worked through Replied, post #36 · Pharmacology › Pharmacokinetics · 29 May 2025 · 3 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
Follow-up: Documentation that appears only after payment Replied, post #75 · Sourcing › Red flags · 14 May 2025 · 6 likes Worth separating two things that post #71 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Cost per milligram, computed honestly across formats — the long version Replied, post #92 · Access › Pricing · 8 May 2025 · 13 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
Carryover and the ghost peak from last week's standard Replied, post #64 · Analytics › HPLC & UHPLC · 9 Apr 2025 · 14 likes Coming back to post #62, because the follow-up matters more than the original answer. System suitability testing: injections run before and during the sample run to…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #101 · Access › International · 15 Mar 2025 · 14 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
Maintainer handover: how it works Replied, post #33 · Meta › Wiki maintenance · 15 Mar 2025 · 5 likes On post #29 — agreed on the reasoning, with one qualification. Review dates: each maintained page has a review date (the date by which it should be checked). If a page…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #36 · Compounds › Semaglutide · 11 Mar 2025 · 1 like This follows post #33 rather than contradicting it. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4…
Checking someone else's arithmetic: a worked example thread Replied, post #27 · Practice › Reconstitution · 6 Mar 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
When to suspect the method rather than the sample Replied, post #88 · Analytics › Method validation · 26 Feb 2025 · 16 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
Protein density versus volume when you cannot eat much Replied, post #26 · Nutrition & Training › Protein & intake · 27 Jan 2025 · 0 likes On post #22 — agreed on the reasoning, with one qualification. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical…
Reading an MS report that only gives you a single number Started this topic · Analytics › Mass spectrometry · 24 Jan 2025 · 7 likes On the subject in the title: Reading an MS report that only gives you a single number Working notes rather than a conclusion. I would like to understand what this…
The topic list is dense — is that deliberate? Replied, post #86 · Meta › Site feedback · 21 Jan 2025 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #3 · Compounds › Tirzepatide · 12 Jan 2025 · 16 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #3 · Compounds › Retatrutide · 4 Jan 2025 · 0 likes Picking up post #2: that is the part I would want checked first. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted…
Holding a dose indefinitely: is there a documented downside? Replied, post #5 · Practice › Dosing & titration · 30 Dec 2024 · 0 likes post #4 answers the question as asked. The question underneath it is different. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #94 · Access › Insurance & coverage · 29 Dec 2024 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
Coming back to: When to suspect the method rather than the sample Replied, post #127 · Analytics › Method validation · 24 Dec 2024 · 18 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Building a sensible monitoring schedule with your prescriber Replied, post #93 · Clinical › Bloodwork · 22 Dec 2024 · 9 likes post #92 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 11 Dec 2024 · 5 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
Journal club: SURMOUNT-1, read without the press release Replied, post #20 · Evidence › Journal club · 28 Nov 2024 · 1 like SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #8 · Compounds › Secretagogues & GH axis · 22 Nov 2024 · 0 likes This follows post #5 rather than contradicting it. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is…
EMA product information as a primary source — does this still hold? Replied, post #11 · Regional › European Union · 14 Nov 2024 · 0 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #32 · Clinical › Prescriber conversations · 5 Nov 2024 · 14 likes post #31 answers the question as asked. The question underneath it is different. Questions about dose: asking "how will we determine whether this dose is working for…
Time to steady state after a dose increase Replied, post #17 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 0 likes Coming back to post #15, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #5 · Wellbeing › Mental health · 25 Sep 2024 · 16 likes I read post #3 twice before replying, because I had assumed the opposite. Substance use: if someone has a history of substance use, appetite suppression and weight loss…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #35 · Analytics › Method validation · 18 Sep 2024 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #24 · Clinical › Special populations · 9 Sep 2024 · 0 likes This follows post #21 rather than contradicting it. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose…
Blind submission and why it changes minds Replied, post #25 · Sourcing › Independent verification · 30 Jul 2024 · 23 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
The mass-error checker and its intended scope Replied, post #19 · Data & Tools › Calculators · 30 May 2024 · 28 likes post #18 is right about the mechanism and I think understates the practical bit. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…